Get in touch to learn how Sentinus.AI can accelerate your drug discovery pipeline
Whether you're looking for AI-designed antibody candidates, companion diagnostics, or want to rescue a failed clinical asset, our team is ready to help.
De novo antibody design in 1-2 months. Perfect for biotech and pharma discovery teams.
Learn More →First-in-class companion diagnostics with full 18-month development path to FDA.
Learn More →AI-driven rescue of failed Phase I/II drugs at 1-10% of original development cost.
Learn More →